In vivo CRISPR screening identifies Ptpn2 as a cancer immunotherapy target
Top Cited Papers
- 19 July 2017
- journal article
- research article
- Published by Springer Science and Business Media LLC in Nature
- Vol. 547 (7664), 413-418
- https://doi.org/10.1038/nature23270
Abstract
Immunotherapy with PD-1 checkpoint blockade is effective in only a minority of patients with cancer, suggesting that additional treatment strategies are needed. Here we use a pooled in vivo genetic screening approach using CRISPR–Cas9 genome editing in transplantable tumours in mice treated with immunotherapy to discover previously undescribed immunotherapy targets. We tested 2,368 genes expressed by melanoma cells to identify those that synergize with or cause resistance to checkpoint blockade. We recovered the known immune evasion molecules PD-L1 and CD47, and confirmed that defects in interferon-γ signalling caused resistance to immunotherapy. Tumours were sensitized to immunotherapy by deletion of genes involved in several diverse pathways, including NF-κB signalling, antigen presentation and the unfolded protein response. In addition, deletion of the protein tyrosine phosphatase PTPN2 in tumour cells increased the efficacy of immunotherapy by enhancing interferon-γ-mediated effects on antigen presentation and growth suppression. In vivo genetic screens in tumour models can identify new immunotherapy targets in unanticipated pathways.Keywords
This publication has 36 references indexed in Scilit:
- Anti-CD47 antibody–mediated phagocytosis of cancer by macrophages primes an effective antitumor T-cell responseProceedings of the National Academy of Sciences of the United States of America, 2013
- High expression of HLA-E in colorectal carcinoma is associated with a favorable prognosisJournal of Translational Medicine, 2011
- Deletion of the protein tyrosine phosphatase gene PTPN2 in T-cell acute lymphoblastic leukemiaNature Genetics, 2010
- Identification of RPS14 as a 5q- syndrome gene by RNA interference screenNature, 2008
- Genome-wide association study of 14,000 cases of seven common diseases and 3,000 shared controlsNature, 2007
- Robust associations of four new chromosome regions from genome-wide analyses of type 1 diabetesNature Genetics, 2007
- Gene set enrichment analysis: A knowledge-based approach for interpreting genome-wide expression profilesProceedings of the National Academy of Sciences of the United States of America, 2005
- Analysis of regulatory CD8 T cells in Qa-1-deficient miceNature Immunology, 2004
- The inhibitory NK cell receptor CD94/NKG2A and the activating receptor CD94/NKG2C bind the top of HLA‐E through mostly shared but partly distinct sets of HLA‐E residuesEuropean Journal of Immunology, 2003
- CD94-NKG2A receptors regulate antiviral CD8+ T cell responsesNature Immunology, 2002